BioXcel Therapeutics, Inc. (BTAIQ): insider trading, Congress trades & who owns it

Insider signal
60/100
Insider buying · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$43K
4 sellers · 12 months
Funds holding
46
13F · Q2 2026
Congress trades
None
none in 2 years

Over the past year there were no insider purchases at BioXcel Therapeutics, Inc.. Four insiders sold roughly $43,000 instead.

Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.

No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. Big money check: 46 institutions held BTAIQ as of Q2 2026, and more funds bought than sold.

Want the full picture on BTAIQ? Price & valuation, financials by quarter, who owns it, dilution, earnings and a written bull & bear case. See what's inside ↓
See the full BTAIQ report — free account

Latest insider trades in BTAIQ

FiledInsiderRoleTypeSharesPriceValueSource
May 22, 2026Yocca FrankExecutive OfficerSell6,845$1.09$7KSEC
May 22, 2026Rodriguez JavierOfficerSell6,560$1.08$7KSEC
May 22, 2026Steinhart Richard ICFOSell6,845$1.09$7KSEC
May 22, 2026Mehta VimalCEOSell19,419$1.09$21KSEC
Dec 17, 2024O'Neill VincentOfficerSell165$0.35$58SEC
Dec 17, 2024Mehta VimalCEOSell983$0.36$354SEC
Dec 17, 2024Mehta VimalCEOSell2,134$0.36$768SEC
Dec 17, 2024Steinhart Richard ICFOSell205$0.36$74SEC
Dec 17, 2024Steinhart Richard ICFOSell372$0.36$134SEC
Dec 17, 2024Rodriguez JavierOfficerSell220$0.36$79SEC
Dec 17, 2024Rodriguez JavierOfficerSell210$0.36$76SEC
Dec 17, 2024Yocca FrankExecutive OfficerSell205$0.36$74SEC
Dec 17, 2024Yocca FrankExecutive OfficerSell225$0.35$79SEC
Oct 3, 2024Wiley Matthew T.Executive OfficerSell6,272$0.55$3KSEC
Oct 3, 2024Yocca FrankExecutive OfficerSell7,175$0.55$4KSEC
The full BTAIQ report

This page shows the insider trades. The full BTAIQ report shows everything around them.

Price and valuation, revenue and profit by quarter, who owns it, dilution, earnings timing and a written bull & bear case, in one report you can also print or save as a PDF. Here is what each section looks like (screenshots from a real report):

CapitalSnitch report section: Live price & key numbers
Live price & key numbersScout

Price, market cap, P/E, revenue and profit growth at a glance.

CapitalSnitch report section: Bull case vs bear case
Bull case vs bear caseAnalyst

A written read of everything below: what supports the stock, what worries.

CapitalSnitch report section: Insider signal score
Insider signal scoreFree

A 0-100 score with the reasons, plus earnings date, volatility and analyst ratings (Analyst).

CapitalSnitch report section: Revenue & profit by quarter
Revenue & profit by quarterScout

Three years of results from SEC filings, growth marked quarter by quarter.

CapitalSnitch report section: Insider buying vs selling by quarter
Insider buying vs selling by quarterScout

Streaks like “7 quarters of net selling” spotted for you.

CapitalSnitch report section: Who owns it (13F)
Who owns it (13F)Scout

Top funds, who added, who cut and who sold out last quarter.

CapitalSnitch report section: Congress trades
Congress tradesFree

Every House and Senate trade in the stock, late filers flagged.

CapitalSnitch report section: Dilution tracker
Dilution trackerAnalyst

Stock offerings, shelf registrations and share-count growth, scored.

CapitalSnitch report section: Snapshot for your trading style
Snapshot for your trading styleAnalyst

Day trading, swing trading and long-term numbers side by side.

Free plan: insider trades, insider signal and Congress trades. Sections marked Scout or Analyst unlock with that plan (from $29/month). Screenshots: Micron Technology report, Oct 19, 2026.

Questions about BTAIQ

Are insiders buying or selling BTAIQ stock?

In the last 12 months BioXcel Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $43,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in BTAIQ?

The most recent open-market insider trade in BTAIQ was filed on 2026-05-22.

How many institutions own BTAIQ?

46 investment managers reported holding BTAIQ in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded BTAIQ?

No congressional trades in BTAIQ were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).